Posttransplant prophylaxis strategies for hepatitis B.
Gane
E
E
D006509:Hepatitis B / Q000517:prevention & control*; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage / Q000627:therapeutic use*; D019259:Lamivudine / Q000627:therapeutic use; D016031:Liver Transplantation / Q000009:adverse effects; D055502:Secondary Prevention
D007136:Immunoglobulins; D019259:Lamivudine; C045213:hepatitis B hyperimmune globulin